aspirin has been researched along with Allergic Reaction in 102 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin-induced asthma (AIA) is a distinct clinical entity characterised by hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe rhinosinusitis." | 8.82 | [Asthma with hypersensitivity to aspirin]. ( Nizankowska-Mogilnicka, E, 2003) |
| "The study included 30 patients with ASA, 30 patients with aspirin-tolerant asthma (ATA) and 30 HS serving as controls." | 7.74 | Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release. ( Borowiec, M; Kowalski, ML; Kurowski, M; Pawliczak, R, 2007) |
| "Three groups, comprising normal subjects (n = 10), aspirin-sensitive asthmatics (ASA+; n = 10) and aspirin-insensitive asthmatics (ASA-; n = 10) were entered into a blinded, parallel group study to asses the modulating effect of aspirin (ASA; 0." | 7.68 | The effect of aspirin on mononuclear cells in aspirin-sensitive asthmatics and control subjects. ( Stewart, GA; Taylor, ML; Thompson, PJ, 1993) |
| " We added aspirin therapy to the treatment regimen of three patients with vernal conjunctivitis." | 7.66 | Aspirin therapy in vernal conjunctivitis. ( Abelson, MB; Butrus, SI; Weston, JH, 1983) |
| "Oral provocation tests with aspirin are important for diagnosis and management in adult and pediatric populations with reported NSAID hypersensitivity." | 5.41 | Recent Updates in Understanding NSAID Hypersensitivity. ( Cahill, K; Minaldi, E, 2023) |
| "Aspirin-induced asthma (AIA) is a distinct clinical entity characterised by hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe rhinosinusitis." | 4.82 | [Asthma with hypersensitivity to aspirin]. ( Nizankowska-Mogilnicka, E, 2003) |
| " Arachidonic acid metabolites seem to be particularly important in the pathogenesis of nasal polyps in patients with aspirin hypersensitivity rhinosinusitis/asthma syndrome." | 4.82 | Pathogenesis of nasal polyps: an update. ( Kowalski, ML; Lewandowska-Polak, A; Pawliczak, R, 2005) |
| "To investigate the safety and outcomes of two-step outpatient NSAID challenges to evaluate patients with non-aspirin-exacerbated respiratory disease (AERD)-related NSAID hypersensitivity." | 4.12 | Safety, Outcomes, and Recommendations for Two-Step Outpatient Nonsteroidal Anti-Inflammatory Drug Challenges. ( Bensko, J; Buchheit, K; Laidlaw, TM; Li, L; Saff, RR, 2022) |
| " CRSwNP may be associated with comorbidity, mainly concerning asthma, aspirin intolerance, and allergy." | 3.96 | Clinical-Cytological-Grading and phenotyping in patients with chronic rhinosinusitis with nasal polyps: the relevance in clinical practice. ( Cassano, M; Ciprandi, G; Gelardi, M; Porro, G; Quaranta, N; Quaranta, V; Study Group On CRSwNP, I, 2020) |
| " Prior known oral NSAIDs hypersensitivity included aspirin (5), mefenamic acid (2), diclofenac (2), Synflex (2) and ibuprofen (1)." | 3.83 | Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link. ( Hsu, AAL; Tan, JHY, 2016) |
| "Nasal polyps are characterized by eosinophilic infiltration, and frequently coexist with asthma, aspirin intolerance and allergy." | 3.75 | Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis. ( Auo, HJ; Joo, YH; Kang, JM; Sun, DI, 2009) |
| "The study included 30 patients with ASA, 30 patients with aspirin-tolerant asthma (ATA) and 30 HS serving as controls." | 3.74 | Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release. ( Borowiec, M; Kowalski, ML; Kurowski, M; Pawliczak, R, 2007) |
| "In the population-based Avon Longitudinal Study of Parents and Children, we measured associations of paracetamol and aspirin use in late pregnancy (20-32 weeks) with asthma, hayfever, eczema (n = 8511) and wheezing (8381) in the offspring at 69-81 months, and with atopy (positive skin prick test to Dermatophagoides pteronyssinus, cat or grass, n = 6527) and blood total IgE (n = 5148) at 7 years." | 3.73 | Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. ( Headley, JE; Henderson, AJ; Jones, RW; Newson, RB; Shaheen, SO; Strachan, DP; Stratton, FD, 2005) |
| "Three groups, comprising normal subjects (n = 10), aspirin-sensitive asthmatics (ASA+; n = 10) and aspirin-insensitive asthmatics (ASA-; n = 10) were entered into a blinded, parallel group study to asses the modulating effect of aspirin (ASA; 0." | 3.68 | The effect of aspirin on mononuclear cells in aspirin-sensitive asthmatics and control subjects. ( Stewart, GA; Taylor, ML; Thompson, PJ, 1993) |
| " There was no significant difference between the polyp histamine levels in patients with a history of asthma, aspirin hypersensitivity, hay fever and positive skin tests." | 3.67 | Free histamine in nasal polyp fluid. ( Bickerton, R; Drake-Lee, AB; McLaughlan, P, 1984) |
| " We added aspirin therapy to the treatment regimen of three patients with vernal conjunctivitis." | 3.66 | Aspirin therapy in vernal conjunctivitis. ( Abelson, MB; Butrus, SI; Weston, JH, 1983) |
| " An analogous mechanism may account for aspirin-induced asthma in man." | 3.66 | Evidence for lipoxygenase pathway involvement in allergic tracheal contraction. ( Burka, JF; Paterson, NA, 1980) |
| "Experimental allergic myocarditis was induced in rabbits; a study was made of the effect on the kininogen content and on the activity of kininase in the myocardium, and on its morphological structure produced by anginine, contrical, aspirin, indometacine and epsilon-aminocapronic acid." | 3.65 | [Changes in the kinin system components and structure of the myocardium under the influence of antikinin preparations in allergic myocarditis in rabbits]. ( Gurevich, MA; Iankovskaia, MO; Odinokova, VA; Paleev, NR; Surovikina, MS, 1976) |
| "The drug allergy practice parameter was developed to provide guidance on the diagnosis and management of drug hypersensitivity reactions." | 3.01 | Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice. ( Banerji, A; Khan, DA; Phillips, EJ; Solensky, R, 2023) |
| "Rhinosinusitis is among the most common infectious complications of humoral immunodeficiency, which is not uncommon in patients with refractory CRS." | 2.46 | Rhinosinusitis and comorbidities. ( Brooks, EG; Ryan, MW, 2010) |
| "Rhinosinusitis is among the most common infectious complications of humoral immunodeficiency, and humoral immunodeficiency is not uncommon in patients with refractory chronic rhinosinusitis." | 2.44 | Diseases associated with chronic rhinosinusitis: what is the significance? ( Ryan, MW, 2008) |
| "Eosinophilia is frequently, but not exclusively, caused by immunoglobulin (Ig)E-mediated hypersensitivity and is dominated by the associated cytokine milieu of Th2 inflammation." | 2.43 | Differential diagnosis of eosinophilic chronic rhinosinusitis. ( Ferguson, BJ; Sok, JC, 2006) |
| "Nasal polyps are histologically characterized by massive edema and accumulation of eosinophils." | 2.39 | Eosinophils in the pathophysiology of nasal polyposis. ( Jankowski, R, 1996) |
| "Aspirin-like drugs inhibit the biosynthesis of prostaglandins in all tissues and species so far studied." | 2.35 | The mode of action of aspirin and similar compounds. ( Vane, JR, 1976) |
| "Sinusitis is both prevalent and costly, affecting more than 14% of the population and costing more than $3." | 1.30 | Medical management of sinusitis. ( Kaliner, M, 1998) |
| "Tissue eosinophilia was a prominent feature of both allergic and nonallergic CHS/NP and correlated in both subgroups with the density of GM-CSF and IL-3 mRNA+ cells." | 1.29 | Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. ( Bean, DK; Cunningham, L; Hamid, Q; Hamilos, DL; Leung, DY; Schotman, E; Wood, R; Yasruel, Z, 1995) |
| "Arterial hypertension was found in 78 of 224 consecutive patients operated for nasal polyposis." | 1.28 | Nasal polyposis as a risk factor for hypertension. ( Granström, G; Jacobsson, E; Jeppsson, PH, 1990) |
| "Prevention of arterial hypoxemia by oxygen breathing blocked an increase in pulmonary vascular resistance in four pretreated responders." | 1.26 | Failure of hypoxic pulmonary vasoconstriction in the canine asthma model. Effect of prostaglandin inhibitors. ( Baier, H; Cohn, MA; Wanner, A, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 64 (62.75) | 18.7374 |
| 1990's | 11 (10.78) | 18.2507 |
| 2000's | 16 (15.69) | 29.6817 |
| 2010's | 4 (3.92) | 24.3611 |
| 2020's | 7 (6.86) | 2.80 |
| Authors | Studies |
|---|---|
| Nunes, IKDC | 1 |
| de Souza, ET | 1 |
| Martins, IRR | 1 |
| Barbosa, G | 1 |
| Moraes Junior, MO | 1 |
| Medeiros, MM | 1 |
| Silva, SWD | 1 |
| Balliano, TL | 1 |
| da Silva, BA | 1 |
| Silva, PMR | 1 |
| Carvalho, VF | 1 |
| Martins, MA | 2 |
| Lima, LM | 1 |
| Li, L | 1 |
| Bensko, J | 1 |
| Buchheit, K | 1 |
| Saff, RR | 1 |
| Laidlaw, TM | 1 |
| Banerji, A | 1 |
| Solensky, R | 1 |
| Phillips, EJ | 1 |
| Khan, DA | 1 |
| Minaldi, E | 1 |
| Cahill, K | 1 |
| Nelson, RK | 1 |
| Bush, A | 1 |
| Stokes, J | 1 |
| Nair, P | 1 |
| Akuthota, P | 1 |
| Studer, MB | 1 |
| Roland, LT | 1 |
| Ochsner, MC | 1 |
| Cox, D | 1 |
| DelGaudio, JM | 1 |
| Wise, SK | 1 |
| Levy, JM | 1 |
| Gelardi, M | 1 |
| Porro, G | 1 |
| Quaranta, V | 1 |
| Quaranta, N | 1 |
| Cassano, M | 1 |
| Ciprandi, G | 1 |
| Study Group On CRSwNP, I | 1 |
| Tan, JHY | 1 |
| Hsu, AAL | 1 |
| Einecke, U | 1 |
| SALEN, EB | 1 |
| ARNER, B | 1 |
| CHRYSANTHIS, K | 1 |
| Sun, DI | 1 |
| Joo, YH | 1 |
| Auo, HJ | 1 |
| Kang, JM | 1 |
| FRIEDLAENDER, S | 1 |
| FEINBERG, SM | 1 |
| Ryan, MW | 2 |
| Brooks, EG | 1 |
| Goodyear-Smith, F | 1 |
| Rogerio, AP | 1 |
| Haworth, O | 1 |
| Croze, R | 1 |
| Oh, SF | 1 |
| Uddin, M | 1 |
| Carlo, T | 1 |
| Pfeffer, MA | 1 |
| Priluck, R | 1 |
| Serhan, CN | 1 |
| Levy, BD | 1 |
| Kheradmand, F | 1 |
| Rishi, K | 1 |
| Corry, DB | 1 |
| Pawankar, R | 1 |
| Humbert, M | 1 |
| UKRAINCZYK-LABORIE, F | 2 |
| LABORIE, R | 3 |
| BLAMOUTIER, P | 2 |
| ROSENFELD, I | 2 |
| SILVERBLATT, M | 2 |
| GRISHMAN, A | 2 |
| WALTON, CH | 2 |
| RANDLE, DL | 1 |
| CAMERON, J | 1 |
| SALVAGGIO, J | 1 |
| CRANE, E | 1 |
| LABORIE, F | 1 |
| CORICCIATI, L | 1 |
| SCHWARZ-SPECK, M | 1 |
| LOZINSKI, E | 1 |
| BRUUN, E | 1 |
| BOLOTINA, AIu | 1 |
| KOMAROVA, VA | 1 |
| Nizankowska-Mogilnicka, E | 1 |
| MATHEWS, KP | 1 |
| LOVELL, RG | 1 |
| SHELDON, JM | 1 |
| BOTTOMLEY, HW | 1 |
| KIND, A | 1 |
| TRETHEWIE, ER | 1 |
| MIRO CARBONELL, A | 1 |
| Shaheen, SO | 1 |
| Newson, RB | 1 |
| Henderson, AJ | 1 |
| Headley, JE | 1 |
| Stratton, FD | 1 |
| Jones, RW | 1 |
| Strachan, DP | 1 |
| Pawliczak, R | 2 |
| Lewandowska-Polak, A | 1 |
| Kowalski, ML | 2 |
| Sok, JC | 1 |
| Ferguson, BJ | 1 |
| Parkinson, JF | 1 |
| Kiley, J | 1 |
| Smith, R | 1 |
| Noel, P | 1 |
| Borowiec, M | 1 |
| Kurowski, M | 1 |
| Campbell, B | 1 |
| Hopkins, C | 1 |
| Browne, JP | 1 |
| Slack, R | 1 |
| Lund, V | 1 |
| Brown, P | 1 |
| Buisseret, PD | 1 |
| Davies, RJ | 1 |
| Moodley, I | 1 |
| Drake-Lee, AB | 1 |
| Bickerton, R | 1 |
| McLaughlan, P | 1 |
| Abelson, MB | 1 |
| Butrus, SI | 1 |
| Weston, JH | 1 |
| Herzog, H | 1 |
| Burka, JF | 1 |
| Paterson, NA | 1 |
| Ramanjaneyulu, R | 1 |
| Madyastha, KM | 1 |
| Bhattacharyya, PK | 1 |
| Ménardo, JL | 1 |
| Bousquet, J | 1 |
| Michel, FB | 1 |
| Hamilos, DL | 1 |
| Leung, DY | 1 |
| Wood, R | 1 |
| Cunningham, L | 1 |
| Bean, DK | 1 |
| Yasruel, Z | 1 |
| Schotman, E | 1 |
| Hamid, Q | 1 |
| Taylor, ML | 1 |
| Stewart, GA | 1 |
| Thompson, PJ | 1 |
| Jankowski, R | 1 |
| Bandeira-Melo, C | 1 |
| Singh, Y | 1 |
| Cordeiro, RS | 1 |
| e Silva, PM | 1 |
| Blanco, C | 2 |
| Quiralte, J | 2 |
| Castillo, R | 1 |
| Delgado, J | 1 |
| Arteaga, C | 1 |
| Barber, D | 1 |
| Carrillo, T | 1 |
| Sánchez-Borges, M | 1 |
| Capriles-Hulett, A | 1 |
| Capriles-Behrens, E | 1 |
| Fernandez-Caldas, E | 1 |
| O'Sullivan, S | 1 |
| Dahlén, B | 1 |
| Roquet, A | 1 |
| Larsson, L | 1 |
| Dahlén, SE | 1 |
| Kumlin, M | 1 |
| Kaliner, M | 1 |
| Krause, W | 1 |
| Gerlach, S | 1 |
| Muschick, P | 1 |
| Narumiya, S | 1 |
| FitzGerald, GA | 1 |
| Okazaki, T | 1 |
| Ilea, VS | 1 |
| Rosario, NA | 1 |
| Reisman, RE | 1 |
| Arbesman, CE | 1 |
| Lee, JB | 1 |
| Middleton, E | 1 |
| Erlings, M | 1 |
| Jongedijk-Brondsted, H | 1 |
| Surovikina, MS | 1 |
| Odinokova, VA | 1 |
| Paleev, NR | 1 |
| Gurevich, MA | 1 |
| Iankovskaia, MO | 1 |
| Chand, N | 1 |
| Eyre, P | 1 |
| Christou, NV | 1 |
| Meakins, JL | 1 |
| Rumack, BH | 1 |
| Cohn, MA | 1 |
| Baier, H | 1 |
| Wanner, A | 1 |
| Settipane, GA | 1 |
| Chafee, FH | 1 |
| Postman, IM | 1 |
| Levine, MI | 1 |
| Saker, JH | 1 |
| Barrick, RH | 1 |
| Nicholas, SS | 1 |
| Schwartz, HJ | 1 |
| Honsinger, RW | 1 |
| Klein, DE | 1 |
| Vane, JR | 1 |
| Moloney, JR | 1 |
| Collins, J | 1 |
| Fisherman, EW | 1 |
| Cohen, GN | 1 |
| Wilson, CW | 1 |
| Delaney, JC | 1 |
| Vannier, E | 1 |
| Lefort, J | 1 |
| Lellouch-Tubiana, A | 1 |
| Terlain, B | 1 |
| Vargaftig, BB | 1 |
| Granström, G | 1 |
| Jacobsson, E | 1 |
| Jeppsson, PH | 1 |
| Williams, WR | 1 |
| Pawlowicz, A | 1 |
| Davies, BH | 1 |
| Kallós, P | 1 |
| Schlumberger, HD | 1 |
| Joseph, M | 1 |
| Capron, A | 1 |
| Tsicopoulos, A | 1 |
| Ameisen, JC | 1 |
| Martinot, JB | 1 |
| Tonnel, AB | 1 |
| Poole, MD | 1 |
| Pillsbury, HC | 1 |
| Proud, D | 1 |
| Kagey-Sobotka, A | 1 |
| Naclerio, RM | 1 |
| Lichtenstein, LM | 1 |
| Katori, M | 1 |
| Dietrich, FM | 1 |
| Komarek, A | 1 |
| Pericin, C | 1 |
| Champion, RH | 1 |
| Calabro, JJ | 1 |
| Katz, RM | 1 |
| Maltz, BA | 1 |
| Ziboh, VA | 1 |
| Blank, H | 1 |
| Huerta López, JG | 1 |
| Martinez Cortés, F | 1 |
| Harkavy, J | 1 |
| Caplin, I | 1 |
| Haynes, JT | 1 |
| Spahn, J | 1 |
| Diamond, GA | 1 |
| Dilibero, RJ | 1 |
| Samter, M | 1 |
| Beers, RF | 1 |
| Feingold, BF | 1 |
| Halpern, B | 1 |
| Lagrue, G | 1 |
| Amache, N | 1 |
| Davis, DJ | 1 |
| Fantini, E | 1 |
| Bonelli, U | 1 |
| Berardi, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Thymoquinone and Olive Oil on Wound Healing After Endoscopic Sinus Surgery in Patients With Nasal Polyposis[NCT06070311] | 50 participants (Anticipated) | Interventional | 2023-10-31 | Not yet recruiting | |||
| Role of Short Term Systemic Corticosteroid Therapy in the Management of Chronic Rhinosinusitis Without Nasal Polyps[NCT01676415] | Phase 4 | 9 participants (Actual) | Interventional | 2012-08-31 | Terminated (stopped due to participants are no longer receiving intervention due to clinical logistics) | ||
| Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis[NCT03472144] | Phase 3 | 60 participants (Anticipated) | Interventional | 2017-07-07 | Recruiting | ||
| High Volume Saline Irrigation in the Post-operative Management of Chronic Rhinosinusitis: A Multicenter Randomized Single-Blind Controlled Trial[NCT02636959] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP). Can Shedding of Epithelial Barrier Proteins be Used as Biomarker in Severe Asthma With/Out CRSwNP Manageme[NCT05365841] | 85 participants (Anticipated) | Observational | 2022-05-15 | Not yet recruiting | |||
| Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery[NCT01680705] | 75 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
| Challenge Test for Acetylsalicylic Acid Hypersensitivity[NCT01681615] | 50 participants (Anticipated) | Interventional | 2012-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The medication side-effect and compliance inventory is a questionnaire to evaluate the frequency and severity of common side effects associated with the medications used in this study. (NCT01676415)
Timeframe: 4-6 weeks and 3 months after initiation of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| Prednisone | 0 |
| Topical Mometasone | 0 |
Change from baseline in individual symptom severity. The taskforce symptom inventory is a visual analog scale of the severity of the 4 major symptoms making up the clinical diagnostic criteria of CRS. (NCT01676415)
Timeframe: 4-6 weeks and 3 months after initiation of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| Prednisone | 0 |
| Topical Mometasone | 0 |
"The Sino-nasal Outcome Test-22 is a validated questionnaire that measures 22 nasal and quality of life symptoms (nasal obstruction and loss of smell and taste) ranked from 0 (not a problem) to 5 (problem as bad as it can be).~Min score= 0, Max score= 110 (worst possible problem on all symptoms)~Change from baseline of the SNOT-22 score. The SNOT-22 questionnaire is a 22-item disease-specific health related quality of life instrument validated for use in chronic rhinosinusitis." (NCT01676415)
Timeframe: 4-6 weeks and 3 months after initiation of treatment
| Intervention | units on a scale (Mean) | |
|---|---|---|
| 4-6 WEEKS | 3 MONTHS | |
| Prednisone | 45.75 | 49 |
| Topical Mometasone | 34.4 | 34.4 |
26 reviews available for aspirin and Allergic Reaction
| Article | Year |
|---|---|
Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Hypersensitivity; Huma | 2023 |
Recent Updates in Understanding NSAID Hypersensitivity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Cyclooxygenase 2 Inhibito | 2023 |
Rhinosinusitis and comorbidities.
Topics: Anti-Bacterial Agents; Aspirin; Cystic Fibrosis; Humans; Hypersensitivity; Immunity, Humoral; Immuno | 2010 |
Environmental contributions to the allergic asthma epidemic.
Topics: Air Pollutants; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Child; Disease Outbreaks; | 2002 |
Nasal polyposis: an update: editorial review.
Topics: Aspirin; Cytokines; Eosinophils; Epithelial Cells; Humans; Hypersensitivity; Inflammation; Mast Cell | 2003 |
[Intrinsic asthma].
Topics: Adult; Age of Onset; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Biomarkers; Cyt | 2003 |
[Asthma with hypersensitivity to aspirin].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Humans; Hypersensitivity; Leukotrienes | 2003 |
Pathogenesis of nasal polyps: an update.
Topics: Aspirin; Bacterial Physiological Phenomena; Cytokines; Eosinophils; Fibroblasts; Fungi; Genetic Pred | 2005 |
Differential diagnosis of eosinophilic chronic rhinosinusitis.
Topics: Animals; Aspirin; Chronic Disease; Diagnosis, Differential; Eosinophilia; Fungi; Humans; Hypersensit | 2006 |
Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Topics: Acetylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Humans; Hy | 2006 |
Asthma phenotypes.
Topics: Aspirin; Asthma; Genetic Predisposition to Disease; Genotype; Glucocorticoids; Humans; Hypersensitiv | 2007 |
Diseases associated with chronic rhinosinusitis: what is the significance?
Topics: Aspirin; Chronic Disease; Cystic Fibrosis; Humans; Hypersensitivity; Immunocompromised Host; Inciden | 2008 |
Antiallergic compounds.
Topics: Adrenal Cortex Hormones; Allergens; Animals; Aspirin; Bronchodilator Agents; Cromolyn Sodium; Histam | 1982 |
Pathophysiological basis of asthma management.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Aspirin; Asthma; Asthma, Exercise-Induced; Bronchi; Bro | 1981 |
Eosinophils in the pathophysiology of nasal polyposis.
Topics: Antigens, CD; Aspirin; Eosinophils; Fibroblasts; Granulocyte-Macrophage Colony-Stimulating Factor; H | 1996 |
A new triad: sensitivity to aspirin, allergic rhinitis, and severe allergic reaction to ingested aeroallergens.
Topics: Adolescent; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Hypersensitivity; | 1997 |
New trends in aspirin sensitivity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Hypersensitivity; Humans; Hypersensi | 1998 |
Genetic and pharmacological analysis of prostanoid receptor function.
Topics: Animals; Aspirin; Biological Transport; Bone Resorption; Cell Nucleus; Colonic Neoplasms; Cyclooxyge | 2001 |
Nonsteroidal anti-inflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Arthritis; Ascariasis; Aspirin; Cattle; Cattle Disea | 1977 |
The mode of action of aspirin and similar compounds.
Topics: Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Bronchi; Dermatitis, Atopic; Drug Hypersensiti | 1976 |
Clinical pharmacological aspects of ascorbic acid.
Topics: Administration, Oral; Aged; Antigen-Antibody Reactions; Ascorbic Acid; Aspirin; Child; Common Cold; | 1975 |
Prostaglandins and other metabolites of arachidonic acid. An overview for the otolaryngologist.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; Blo | 1985 |
[Prostaglandins and related substances: regulation of arachidonic acid metabolism by drugs].
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Butylated Hy | 1985 |
A critical reappraisal of juvenile rheumatoid arthritis.
Topics: Agammaglobulinemia; Arthritis, Juvenile; Aspirin; Cardiomegaly; Child; Child, Preschool; Chloroquine | 1971 |
[Role of prostaglandins in the skin].
Topics: Animals; Aspirin; Chemical Phenomena; Chemistry; Cyclic AMP; Humans; Hypersensitivity; Infections; P | 1973 |
Cardiac manifestations due to hypersensitivity.
Topics: Adams-Stokes Syndrome; Anaphylaxis; Angina Pectoris; Antigen-Antibody Complex; Arrhythmias, Cardiac; | 1970 |
2 trials available for aspirin and Allergic Reaction
| Article | Year |
|---|---|
Significance of tartrazine sensitivity in chronic urticaria of unknown etiology.
Topics: Adult; Aspirin; Azo Compounds; Benzenesulfonates; Chronic Disease; Clinical Trials as Topic; Eosinop | 1976 |
Pharmacologic modification of the immediate intradermal skin reaction.
Topics: Aspirin; Chlorpromazine; Clinical Trials as Topic; Diphenhydramine; Ephedrine; Humans; Hypersensitiv | 1966 |
74 other studies available for aspirin and Allergic Reaction
| Article | Year |
|---|---|
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; H | 2020 |
Safety, Outcomes, and Recommendations for Two-Step Outpatient Nonsteroidal Anti-Inflammatory Drug Challenges.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Drug Hypersensitivity; Fe | 2022 |
Eosinophilic Asthma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Biomarkers; Child; Humans; Hypersensitivit | 2020 |
Aspirin-Exacerbated Respiratory Disease With Allergic Fungal Rhinosinusitis: A Case Series of Overlapping Sinonasal Endotypes.
Topics: Allergens; Aspirin; Asthma, Aspirin-Induced; Chronic Disease; Desensitization, Immunologic; Female; | 2020 |
Clinical-Cytological-Grading and phenotyping in patients with chronic rhinosinusitis with nasal polyps: the relevance in clinical practice.
Topics: Adult; Aspirin; Asthma; Cell Biology; Chronic Disease; Comorbidity; Cross-Sectional Studies; Female; | 2020 |
Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspi | 2016 |
[From wheezing to anaphylactic shock: allergology for your practice].
Topics: Adult; Allergy and Immunology; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2008 |
Some views on the aspirin-hypersensitive allergy group.
Topics: Anaphylaxis; Aspirin; Drug Hypersensitivity; Humans; Hypersensitivity; Immune System Diseases | 1948 |
Allergy to aspirin in a family; report of a case.
Topics: Aspirin; Hypersensitivity; Immune System Diseases; Salicylates | 1947 |
Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis.
Topics: Adult; Aged; Antimicrobial Cationic Peptides; Aspirin; Asthma; Drug Hypersensitivity; Eosinophilia; | 2009 |
Aspirin allergy; its relationship to chronic intractable asthma.
Topics: Aspirin; Asthma; Drug Hypersensitivity; Hypersensitivity; Salicylates | 1947 |
Feverfew. Bachelor's buttons, Featherfew (Tanacetum parthenium L. aka Chrysanthemum parthenium L. aka Pyrethrum parthenium L.).
Topics: Arthritis, Rheumatoid; Aspirin; Drug Interactions; Gastrointestinal Diseases; Humans; Hypersensitivi | 2010 |
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses.
Topics: Animals; Aspirin; Asthma; Blotting, Western; Bronchoalveolar Lavage Fluid; Chemotaxis, Leukocyte; Cy | 2012 |
[Some aspects of physiology in the allergic and the possibility of their suppression by acetylsalicylic acid and a fat-free diet].
Topics: Aspirin; Diet; Diet, Fat-Restricted; Humans; Hypersensitivity; Immune System Diseases | 1953 |
[Allergy to aspirin in patients with asthma].
Topics: Aspirin; Asthma; Humans; Hypersensitivity; Immune System Diseases | 1954 |
[Certain physiopathological aspects in allergic persons and the possibility of their control by a fat-free diet and by acetylsalicylic acid].
Topics: Aspirin; Diet; Diet, Fat-Restricted; Fats; Humans; Hypersensitivity; Immune System Diseases | 1954 |
Allergic shock in humans: report of two cases with electrocardiographic findings.
Topics: Aspirin; Electrocardiography; Histamine; Humans; Hypersensitivity | 1957 |
Allergic shock in humans: report of two cases with electrocardiographic findings.
Topics: Aspirin; Electrocardiography; Histamine; Humans; Hypersensitivity | 1957 |
Allergic shock in humans: report of two cases with electrocardiographic findings.
Topics: Aspirin; Electrocardiography; Histamine; Humans; Hypersensitivity | 1957 |
Allergic shock in humans: report of two cases with electrocardiographic findings.
Topics: Aspirin; Electrocardiography; Histamine; Humans; Hypersensitivity | 1957 |
Aspirin allergy.
Topics: Aspirin; Drug Hypersensitivity; Humans; Hypersensitivity | 1957 |
The effect of aspirin, cortisone and other compounds on susceptibility to anaphylactic shock in mice.
Topics: Anaphylaxis; Animals; Aspirin; Cortisone; Disease Susceptibility; Hypersensitivity; Immune System Di | 1957 |
Severe allergic reaction after ingestion of acetylsalicylic acid compounds.
Topics: Aspirin; Humans; Hypersensitivity | 1961 |
[Intermediate metabolism in the allergic subject and the oxidizing biological effect of acetylsalicylic acid. (Eperimental study in men and animals)].
Topics: Animals; Aspirin; Blood Glucose; Cholesterol; Humans; Hypersensitivity; Immune System Diseases; Lipi | 1961 |
[Allergy to aspirin. Gastric nemorrnages preceding the appearance of asthma, urticaria or Quincke's edema].
Topics: Angioedema; Aspirin; Asthma; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Hypersensitivity; Urti | 1960 |
[Hemorrhagic cystitis and allergy to drugs].
Topics: Aspirin; Cystitis; Hemorrhage; Humans; Hypersensitivity; Immune System Diseases; Medical Records | 1960 |
[Gel-diffusion methods in 2 cases of allergy].
Topics: Aspirin; Diffusion; Humans; Hypersensitivity; Immune Sera; Immune System Diseases | 1961 |
THE COMPARATIVE PHARMACOLOGY.
Topics: Acetaminophen; Acetanilides; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Aspirin; Blood Coag | 1963 |
[DRUG ALLERGY IN PATIENTS SUFFERING FROM ALLERGIC DISEASES WITH IMMEDIATE REACTION].
Topics: Anaphylaxis; Anti-Bacterial Agents; Aspirin; Asthma; Barbiturates; Codeine; Drug Eruptions; Drug Hyp | 1964 |
[ON ALLERGIC REACTIONS IN THE PREVENTIVE TREATMENT OF RHEUMATISM WITH BICILLIN AND ASPIRIN].
Topics: Aspirin; Drug Hypersensitivity; Drug Therapy; Ethylenediamines; Humans; Hypersensitivity; Penicillin | 1964 |
The problem of aspirin allergy with a report on skin testing with salicylate-containing human sera.
Topics: Aspirin; Drug Hypersensitivity; Humans; Hypersensitivity; Salicylates; Skin; Skin Tests | 1950 |
Allergy to aspirin.
Topics: Aspirin; Asthma; Humans; Hypersensitivity | 1951 |
[Hypersensitivity to aspirin in bronchial asthma].
Topics: Aspirin; Asthma; Humans; Hypersensitivity | 1951 |
[Allergy to aspirin].
Topics: Aspirin; Hypersensitivity; Immune System Diseases | 1951 |
The influence of sodium salicylate and acetyl salicylic acid on the release of histamine in anaphylaxis.
Topics: Anaphylaxis; Aspirin; Histamine; Humans; Hypersensitivity; Immune System Diseases; Salicylates; Sodi | 1951 |
[Severe histaminic shock caused by aspirin].
Topics: Anaphylaxis; Aspirin; Humans; Hypersensitivity | 1950 |
Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; As | 2005 |
Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
Topics: Adult; Aged; Alternative Splicing; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Cycloox | 2007 |
Inhibition of Anaphylactic Shock by Acetylsalicylic Acid.
Topics: Anaphylaxis; Aspirin; Hypersensitivity; Immune System Diseases; Salicylates | 1948 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
Allergy.
Topics: Animals; Antibody Formation; Arachidonic Acids; Aspirin; Autacoids; B-Lymphocytes; Cromolyn Sodium; | 1982 |
Free histamine in nasal polyp fluid.
Topics: Aspirin; Asthma; Drug Hypersensitivity; Extracellular Space; Histamine; Humans; Hypersensitivity; Na | 1984 |
Aspirin therapy in vernal conjunctivitis.
Topics: Adolescent; Aspirin; Child; Conjunctivitis; Female; Histamine; Humans; Hypersensitivity; Male; Mast | 1983 |
Evidence for lipoxygenase pathway involvement in allergic tracheal contraction.
Topics: Animals; Arachidonic Acids; Aspirin; Asthma; Constriction, Pathologic; Guinea Pigs; Histamine; Hyper | 1980 |
Chemical approach to aspirin hypersensitivity.
Topics: Animals; Aspirin; Female; Guinea Pigs; Haptens; Hypersensitivity; Immunodiffusion; Male; Rabbits; Se | 1981 |
Comparison of three prick test methods with the intradermal test and with the rast in the diagnosis of mite allergy.
Topics: Adolescent; Adult; Aged; Aspirin; Asthma; Child; Drug Hypersensitivity; Humans; Hypersensitivity; Im | 1982 |
Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis.
Topics: Adolescent; Adult; Aspirin; Cell Movement; Cytokines; Drug Hypersensitivity; Eosinophilia; Eosinophi | 1995 |
The effect of aspirin on mononuclear cells in aspirin-sensitive asthmatics and control subjects.
Topics: Aspirin; Asthma; Humans; Hypersensitivity; In Vitro Techniques; Lymphocyte Activation; Lymphocyte Su | 1993 |
Involvement of prostaglandins in the down-regulation of allergic plasma leakage observed in rats undergoing pleural eosinophilia.
Topics: Animals; Aspirin; Dinoprostone; Down-Regulation; Eosinophils; Female; Hypersensitivity; Indomethacin | 1996 |
Anaphylaxis after ingestion of wheat flour contaminated with mites.
Topics: Adolescent; Adult; Allergens; Anaphylaxis; Animals; Antibodies, Monoclonal; Antigens, Dermatophagoid | 1997 |
Urinary 9 alpha, 11 beta-PGF2 as a marker of mast cell activation in allergic and aspirin-intolerant asthma.
Topics: Antibodies; Antibody Specificity; Aspirin; Asthma; Biomarkers; Chromatography, High Pressure Liquid; | 1997 |
Medical management of sinusitis.
Topics: Adrenal Cortex Hormones; Aspirin; Drainage; Humans; Hypersensitivity; Nasal Decongestants; Nasal Sep | 1998 |
Prevention of the hemodynamic effects of iopromide-carrying liposomes in rats and pigs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contrast Media; Data Interpretation, Stat | 2000 |
Regulatory role of prostaglandin E in allergic histamine release with observations on the responsiveness of basophil leukocytes and the effect of acetylsalicylic acid.
Topics: Antibody Specificity; Aspirin; Basophils; Dose-Response Relationship, Drug; Histamine Release; Human | 1977 |
[Etiology of urticaria; a retrospective study on 200 patients].
Topics: Acute Disease; Aspirin; Chronic Disease; Drug Eruptions; Humans; Hypersensitivity; Psychophysiologic | 1976 |
[Changes in the kinin system components and structure of the myocardium under the influence of antikinin preparations in allergic myocarditis in rabbits].
Topics: Aminocaproic Acid; Animals; Aprotinin; Aspirin; Heart; Hypersensitivity; Indomethacin; Kininogens; K | 1976 |
Neutrophil function in anergic surgical patients: neutrophil adherence and chemotaxis.
Topics: Adolescent; Adult; Aged; Ascorbic Acid; Aspirin; Chemotaxis, Leukocyte; Ethanol; Female; Humans; Hyd | 1979 |
Aspirin and acetaminophen.
Topics: Acetaminophen; Antidotes; Arthritis, Juvenile; Aspirin; Child, Preschool; Female; Hemostasis; Humans | 1979 |
Failure of hypoxic pulmonary vasoconstriction in the canine asthma model. Effect of prostaglandin inhibitors.
Topics: Animals; Ascaris; Aspirin; Asthma; Dogs; Hypersensitivity; Hypoxia; Indomethacin; Lung; Oxygen; Pros | 1978 |
Nasal polyps and bronchial asthma.
Topics: Aspirin; Asthma; Drug Hypersensitivity; Humans; Hypersensitivity; Nasal Mucosa; Nasal Polyps | 1977 |
Ibuprofen (motrin) hypersensitivity in intrinsic and extrinsic allergic patients.
Topics: Aspirin; Blood Coagulation Tests; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Drug Hypersens | 1976 |
The diagnosis of aspirin idiosyncrasy by analgesic challenge.
Topics: Acetaminophen; Adolescent; Adult; Aged; Airway Obstruction; Aspirin; Asthma; Drug Hypersensitivity; | 1976 |
Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs.
Topics: Animals; Antigens; Aspirin; Bronchoconstriction; Cell Degranulation; Endotoxins; Escherichia coli; G | 1991 |
Nasal polyposis as a risk factor for hypertension.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Asthma; C | 1990 |
Aspirin-like effects of selected food additives and industrial sensitizing agents.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Female; Food Additives; Huma | 1989 |
Pseudo-allergic reactions--PAR.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antigen-Antibody Reactions; Aspirin; Asthma; Blood Platelet | 1987 |
Platelet activation by IgE and aspirin.
Topics: Animals; Aspirin; Asthma; Blood Platelets; Cytotoxicity, Immunologic; Humans; Hypersensitivity; Immu | 1987 |
Pharmacology of upper airways challenge.
Topics: Aspirin; Cyproheptadine; Exocytosis; Humans; Hypersensitivity; Inflammation; Mast Cells; Nasal Mucos | 1987 |
Hypersensitivity in mice. II. The effect of chemical compounds on systemic active anaphylaxis and on anaphylaxis-like reactions in normal and B. pertussis-pretreated mice.
Topics: Anaphylaxis; Animals; Antigens; Aspirin; Bordetella pertussis; Chloroquine; Corticosterone; Cortison | 1971 |
Diseases of the skin. Drug therapy of urticaria.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aspirin; Diet; Drug Therapy, Combination; Epinephr | 1973 |
[Effect of aspirin on the response to the intradermal injection of bradykinin].
Topics: Aspirin; Bradykinin; Evaluation Studies as Topic; Humans; Hypersensitivity; Injections, Intradermal; | 1973 |
Are nasal polyps an allergic phenomenon?
Topics: Aspirin; Asthma; Cystic Fibrosis; Dermatitis, Atopic; Drug Hypersensitivity; Female; Humans; Hyperse | 1971 |
Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.
Topics: Adult; Age Factors; Allergens; Angioedema; Aspirin; Asthma; Chemical Phenomena; Chemistry; Drug Hype | 1968 |
Recognition of food additives as a cause of symptoms of allergy.
Topics: Aspirin; Color; Diet; Flavoring Agents; Food Additives; Haptens; Humans; Hypersensitivity; Nasal Pol | 1968 |
[Lymphoblastic transformation test in allergology].
Topics: Antigen-Antibody Reactions; Aspirin; Drug Hypersensitivity; Humans; Hypersensitivity; In Vitro Techn | 1968 |
The NIAID: its role and goal.
Topics: Aspirin; Bronchitis; Drug Hypersensitivity; Hypersensitivity; Infections; Male; National Institutes | 1969 |
[Contribution to the study of cutaneous vasculitis. I. "Allergic vasculitis"].
Topics: Aspirin; Child; Drug Hypersensitivity; Female; Humans; Hypersensitivity; Male; Middle Aged; Phenacet | 1966 |